These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29228695)

  • 1. Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.
    Liu G; Dong C; Wang X; Hou G; Zheng Y; Xu H; Zhan X; Liu L
    Oncotarget; 2017 Nov; 8(58):98360-98370. PubMed ID: 29228695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    Diao R; Mu X; Wang T; Li S
    PLoS One; 2017; 12(8):e0182908. PubMed ID: 28796819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.
    Shi M; He J
    PeerJ; 2016; 4():e1804. PubMed ID: 26989635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-related gene-based model predicts the survival of colorectal carcinoma and reflected various biological statuses.
    Kang Z; Chen B; Ma X; Yan F; Wang Z
    Front Mol Biosci; 2023; 10():1277933. PubMed ID: 37920710
    [No Abstract]   [Full Text] [Related]  

  • 5. Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients.
    Cheng X; Hu M; Chen C; Hou D
    Cancer Manag Res; 2018; 10():2945-2952. PubMed ID: 30214289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Gene Expression Regulation Through m
    Zhou Z; Mo S; Gu R; Dai W; Zou X; Han L; Zhang L; Wang R; Cai G
    Front Oncol; 2020; 10():572708. PubMed ID: 33102231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
    Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
    Front Oncol; 2021; 11():776997. PubMed ID: 34926285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer.
    Xin C; Lai Y; Ji L; Wang Y; Li S; Hao L; Zhang W; Meng R; Xu J; Hong Y; Lou Z
    Front Genet; 2022; 13():1097234. PubMed ID: 36704343
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
    Bu L; Huang F; Li M; Peng Y; Wang H; Zhang M; Peng L; Liu L; Zhao Q
    PeerJ; 2021; 9():e11430. PubMed ID: 34035992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Stage II Colorectal Cancer Recurrence Associated Genes by Microarray Meta-Analysis and Building Predictive Models with Machine Learning Algorithms.
    Lu W; Pan X; Dai S; Fu D; Hwang M; Zhu Y; Zhang L; Wei J; Kong X; Li J; Xiao Q; Ding K
    J Oncol; 2021; 2021():6657397. PubMed ID: 33628243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients.
    Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK
    Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer.
    Fu J; Du F; Tian T; Huang H; Zhang L; Li D; Liu Y; Zhang D; Gao L; Zheng T; Liu Y; Zhao Y
    BMC Cancer; 2023 Jul; 23(1):620. PubMed ID: 37400788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer.
    Tian X; Zhu X; Meng W; Bai S; Shi M; Xiang S; Zhao C; Wang Y
    Aging (Albany NY); 2020 Aug; 12(18):18363-18383. PubMed ID: 32855365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer.
    Lin XT; Wu QN; Qin S; Fan DJ; Lv MY; Chen X; Cai JW; Weng JR; Zou YF; Rong YM; Gao F
    Front Genet; 2021; 12():755789. PubMed ID: 34899841
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
    Xu K; He J; Zhang J; Liu T; Yang F; Ren T
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer.
    An N; Shi X; Zhang Y; Lv N; Feng L; Di X; Han N; Wang G; Cheng S; Zhang K
    PLoS One; 2015; 10(9):e0137171. PubMed ID: 26325386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
    Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
    Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene expression-based risk model reveals prognosis of gastric cancer.
    Deng X; Xiao Q; Liu F; Zheng C
    PeerJ; 2018; 6():e4204. PubMed ID: 29441228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.